Bayforest Capital’s Centessa Pharmaceuticals CNTA Stock Holding History

Bayforest Capital’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,947	Closed	-$77.3K	–	997
2026 Q1	$77.3K	Buy	+1,947	New	+$49.8K	0.09%	442

Bayforest Capital's CNTA Position: Q2 2026 in Review

Bayforest Capital sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 1,947 shares — an estimated $77.3K sold.

Bayforest Capital first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $77.3K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Bayforest Capital reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Bayforest Capital sold 1,947 Centessa Pharmaceuticals shares in Q2 2026, an estimated $77.3K.
Bayforest Capital first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Bayforest Capital's Centessa Pharmaceuticals position peaked at $77.3K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.